Overview

The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of topical application of IDP-108 versus vehicle in treating patients with onychomycosis.
Phase:
Phase 3
Details
Lead Sponsor:
Dow Pharmaceutical Sciences